Endostar, a novel recombinant human (rh)endostatin purified in E. coli, was evaluated in a single-arm phase II trial in combination with chemotherapy in patients with extensive stage (ED) SCLC (19). This evidence concerns the gene COL18A1 and small cell lung carcinoma.